Figure 4. Plasma concentrations of VEGF and Flt3 ligand. ELISA determinations of plasma levels of VEGF (A) and Flt3 ligand (B) taken pretreatment (□), on day 8 (▨) , and on day 28 (▪) of the first cycle in all patients on treatment.
Figure 4.

Plasma concentrations of VEGF and Flt3 ligand. ELISA determinations of plasma levels of VEGF (A) and Flt3 ligand (B) taken pretreatment (□), on day 8 (▨) , and on day 28 (▪) of the first cycle in all patients on treatment.

This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal